My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 143

    1.

    Spare the rod and spoil the eye.

    Arden GB, Sidman RL, Arap W, Schlingemann RO.

    Br J Ophthalmol. 2005 Jun;89(6):764-9. Review.PMID: 15923516 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Role of the vascular endothelial growth factor isoforms in retinal angiogenesis and DiGeorge syndrome.

    Stalmans I.

    Verh K Acad Geneeskd Belg. 2005;67(4):229-76. Review.PMID: 16334858 [PubMed - indexed for MEDLINE]Related articles

    3.

    Anti-vascular endothelial growth factor therapy for ocular neovascular disease.

    Andreoli CM, Miller JW.

    Curr Opin Ophthalmol. 2007 Nov;18(6):502-8. Review.PMID: 18163003 [PubMed - indexed for MEDLINE]Related articles

    4.

    [Aging and retinal vascular diseases]

    Takagi H.

    Nippon Ganka Gakkai Zasshi. 2007 Mar;111(3):207-30; discussion 231. Review. Japanese. PMID: 17402563 [PubMed - indexed for MEDLINE]Related articles

    5.

    VEGF165b, an endogenous C-terminal splice variant of VEGF, inhibits retinal neovascularization in mice.

    Konopatskaya O, Churchill AJ, Harper SJ, Bates DO, Gardiner TA.

    Mol Vis. 2006 May 26;12:626-32.PMID: 16735996 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    [Molecular pathogenesis of ocular vascular disease--anti-angiogenesis as a therapeutic concept]

    Joussen AM.

    Dtsch Med Wochenschr. 2007 Jun 8;132(23):1268-72. Review. German. PMID: 17541869 [PubMed - indexed for MEDLINE]Related articles

    7.

    [Angiogenesis and retinal diseases]

    Damico FM.

    Arq Bras Oftalmol. 2007 May-Jun;70(3):547-53. Review. Portuguese. PMID: 17768570 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Vascular endothelial growth factor in eye disease.

    Penn JS, Madan A, Caldwell RB, Bartoli M, Caldwell RW, Hartnett ME.

    Prog Retin Eye Res. 2008 Jul;27(4):331-71. Epub 2008 May 28. Review.PMID: 18653375 [PubMed - indexed for MEDLINE]Related articles

    9.

    Combination therapy for the treatment of ocular neovascularization.

    Bradley J, Ju M, Robinson GS.

    Angiogenesis. 2007;10(2):141-8. Epub 2007 Mar 13. Review.PMID: 17372853 [PubMed - indexed for MEDLINE]Related articles

    10.

    Oxygen-dependent diseases in the retina: role of hypoxia-inducible factors.

    Arjamaa O, Nikinmaa M.

    Exp Eye Res. 2006 Sep;83(3):473-83. Epub 2006 Jun 5. Review.PMID: 16750526 [PubMed - indexed for MEDLINE]Related articles

    11.

    Erythropoietin as a retinal angiogenic factor in proliferative diabetic retinopathy.

    Watanabe D, Suzuma K, Matsui S, Kurimoto M, Kiryu J, Kita M, Suzuma I, Ohashi H, Ojima T, Murakami T, Kobayashi T, Masuda S, Nagao M, Yoshimura N, Takagi H.

    N Engl J Med. 2005 Aug 25;353(8):782-92.PMID: 16120858 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    [Angioproliferative retinal disease caused by ischemia]

    Agostini HT, Hansen LL.

    Ophthalmologe. 2003 May;100(5):371-7. Review. German. PMID: 12748802 [PubMed - indexed for MEDLINE]Related articles

    13.

    Retinopathy is reduced during experimental diabetes in a mouse model of outer retinal degeneration.

    de Gooyer TE, Stevenson KA, Humphries P, Simpson DA, Gardiner TA, Stitt AW.

    Invest Ophthalmol Vis Sci. 2006 Dec;47(12):5561-8.PMID: 17122149 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Effects of brief, clustered versus dispersed hypoxic episodes on systemic and ocular growth factors in a rat model of oxygen-induced retinopathy.

    Coleman RJ, Beharry KD, Brock RS, Abad-Santos P, Abad-Santos M, Modanlou HD.

    Pediatr Res. 2008 Jul;64(1):50-5.PMID: 18344903 [PubMed - indexed for MEDLINE]Related articles

    15.

    Rod photoreceptor loss in Rho-/- mice reduces retinal hypoxia and hypoxia-regulated gene expression.

    de Gooyer TE, Stevenson KA, Humphries P, Simpson DA, Curtis TM, Gardiner TA, Stitt AW.

    Invest Ophthalmol Vis Sci. 2006 Dec;47(12):5553-60.PMID: 17122148 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Inhibition of NAD(P)H oxidase activity blocks vascular endothelial growth factor overexpression and neovascularization during ischemic retinopathy.

    Al-Shabrawey M, Bartoli M, El-Remessy AB, Platt DH, Matragoon S, Behzadian MA, Caldwell RW, Caldwell RB.

    Am J Pathol. 2005 Aug;167(2):599-607.PMID: 16049343 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Vascular endothelial growth factor and diabetic retinopathy: role of oxidative stress.

    Caldwell RB, Bartoli M, Behzadian MA, El-Remessy AE, Al-Shabrawey M, Platt DH, Liou GI, Caldwell RW.

    Curr Drug Targets. 2005 Jun;6(4):511-24. Review.PMID: 16026270 [PubMed - indexed for MEDLINE]Related articles

    18.

    [Expression of mRNA of vascular endothelial growth factor in a rat model of hyperoxia-induced retinopathy]

    Zhang ZH, Jiang L, Qiao LX.

    Zhongguo Dang Dai Er Ke Za Zhi. 2007 Aug;9(4):371-4. Chinese. PMID: 17706045 [PubMed - indexed for MEDLINE]Related articles

    19.

    Implication of the hypoxia response element of the Vegf promoter in mouse models of retinal and choroidal neovascularization, but not retinal vascular development.

    Vinores SA, Xiao WH, Aslam S, Shen J, Oshima Y, Nambu H, Liu H, Carmeliet P, Campochiaro PA.

    J Cell Physiol. 2006 Mar;206(3):749-58.PMID: 16245301 [PubMed - indexed for MEDLINE]Related articles

    20.

    Triamcinolone suppresses retinal vascular pathology via a potent interruption of proinflammatory signal-regulated activation of VEGF during a relative hypoxia.

    Kim YH, Chung IY, Choi MY, Kim YS, Lee JH, Park CH, Kang SS, Roh GS, Choi WS, Yoo JM, Cho GJ.

    Neurobiol Dis. 2007 Jun;26(3):569-76. Epub 2007 Feb 9.PMID: 17434742 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity